Correction to “Structure‐based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFree Radicals and Antioxidants · bioluminescence and chemiluminescence research · Electron Spin Resonance Studies
Islam S, Amin MA, Rengasamy KRR, Mohiuddin AKM, Mahmud S. Structure‐based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach. Cancer Med. 2024;13(15):e70074. doi:10.1002/cam4.70074.
A second affiliation has been added for Kannan R. R. Rengasamy and reads as follows:
^3^Centre of Excellence for Pharmaceutical Sciences, North‐West University, Potchefstroom, 2520, South Africa.
An acknowledgment section has been added and reads as follows:
Kannan R.R. Rengasamy acknowledges the Centre for High Performance Computing (CHPC), South Africa, for providing computational resources to this research project.
We apologize for this error.